Location: Philadelphia, PA
Co-founder and CEO
Freenome, Inc. creates non-invasive blood tests for cancer and other age-associated diseases. For example, the company has created a test that can not only detect stage-one cancer, but also distinguish between different types of cancer. Freenome is now working in partnership with several universities to create a version of the test that can also suggest which treatment is likely to yield the best results.
WORDS OF WISDOM: “What we’re trying to do as a company is really trying to change people’s mentality into thinking, you do need to take these regular tests, you do need to take care of yourself as you age.”
Co-founder and CEO Gabriel Otte believes Freenome’s testing solution has the potential to transform how people think about healthcare. “For the last 2,000 years, we’ve been practicing symptomatic medicine, which means you go to the doctor when you have a symptom, and you get treated [for it]. With diseases like cancer and Alzheimer’s disease … it’s too late to cure these diseases by the time you have symptoms,” he says. By creating a test that patients can easily take during their annual physical, Freenome hopes to move healthcare toward asymptomatic practice.